http://www.interceptpharma.com
Intercept Pharmaceuticals, Inc. Company Intro
We are INTERCEPT. Our mission is to build a healthier tomorrow for patients with progressive non-viral liver diseases.
Industry
Healthcare
Intercept Pharmaceuticals, Inc. Headquaters
10 Hudson Yards
New York,10001
United States
Intercept Pharmaceuticals, Inc. Share price
17 May 2023 13:22 GMT
$16.06
-0.39 (-2.37 %)
Intercept Pharmaceuticals, Inc. Market cap
$675.748 M
WMC RANKING
2024
Intercept Pharmaceuticals, Inc. # 35
BiotechnologyLatest Intercept Pharmaceuticals, Inc. News
12 Feb 2024
Global Non-alcoholic Steatohepatitis Drugs Pipeline Industry Expected to Hit $51.36 Billion by 2033, Propelled by a ...
In a remarkable turn of events, the Global Non-alcoholic Steatohepatitis Drugs Pipeline Industry is poised for an extraordinary valuation of US$ 0.27...
12 Feb 2024
Gilead boosts portfolio with $4.3B Cymabay acquisition
Gilead Sciences Inc. is taking over Cymabay Therapeutics Inc. for $32.50 per share in cash, for a total equity value of $4.3 billion to bring aboard...
12 Feb 2024
CymaBay Therapeutics Stock (NASDAQ:CBAY), Quotes and News Summary
CymaBay Therapeutics Stock (NASDAQ: CBAY) stock price, news, charts, stock research, profile.
WMC Market Score
WMC Market to Revenue Score
Intercept Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Intercept Pharmaceuticals, Inc. | USD | $321,699 | $478,770 | $-222,317 | $6,757M | 35 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Intercept Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Intercept Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Intercept Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Intercept Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Intercept Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Intercept Pharmaceuticals, Inc. | 3.50 | 22.59 | 0.04 | 0 | 0 | 0 | 8.07 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
